Patent application number | Description | Published |
20080201640 | System and Method for Creating and Navigating a Linear Hypermedia Resource Program - A method and system for creating and navigating linear hypermedia resource programs are disclosed. The system includes a distributed hypermedia resource network having a plurality of hypermedia resources residing on one or more remote information nodes. A common remote information node is in communication with a subscriber station and the remote information nodes in the distributed network. The common remote information node contains at least one linear hypermedia resource program consisting of pre-selected media elements from one or more hypermedia resources linked with exclusive linear links, each media element in the linear program having only one forward link to the next media element. The method includes the steps of downloading and displaying a media element in the linear program and responding to user commands to download and display the next media element in the linear program. | 08-21-2008 |
20090074170 | METHOD, SYSTEM, AND ARTICLE FOR AUDIBLY IDENTIFYING A CALLED PARTY - A dialed number of a called party is received from a calling party. Based on the dialed number, a name of the called party is retrieved from a database. An audio message which includes the name of the called party is generated and communicated to the calling party. A call is routed between the calling party and the called party after said communicating the audio message. | 03-19-2009 |
20090204684 | SYSTEM AND METHOD FOR CREATING AND NAVIGATING A LINEAR HYPERMEDIA RESOURCE PROGRAM - A method and system for creating and navigating linear hypermedia resource programs are disclosed. The system includes a distributed hypermedia resource network having a plurality of hypermedia resources residing on one or more remote information nodes. A common remote information node is in communication with a subscriber station and the remote information nodes in the distributed network. The common remote information node contains at least one linear hypermedia resource program consisting of pre-selected media elements from one or more hypermedia resources linked with exclusive linear links, each media element in the linear program having only one forward link to the next media element. The method includes the steps of downloading and displaying a media element in the linear program and responding to user commands to download and display the next media element in the linear program. | 08-13-2009 |
20110231761 | SYSTEM AND METHOD FOR CREATING AND NAVIGATING A LINEAR HYPERMEDIA RESOURCE PROGRAM - A method and system for creating and navigating linear hypermedia resource programs are disclosed. The system includes a distributed hypermedia resource network having a plurality of hypermedia resources residing on one or more remote information nodes. A common remote information node is in communication with a subscriber station and the remote information nodes in the distributed network. The common remote information node contains at least one linear hypermedia resource program consisting of pre-selected media elements from one or more hypermedia resources linked with exclusive linear links, each media element in the linear program having only one forward link to the next media element. The method includes the steps of downloading and displaying a media element in the linear program and responding to user commands to download and display the next media element in the linear program. | 09-22-2011 |
20120284621 | SYSTEM AND METHOD FOR CREATING AND NAVIGATING A LINEAR HYPERMEDIA RESOURCE PROGRAM - A method and system for creating and navigating linear hypermedia resource programs are disclosed. The system includes a distributed hypermedia resource network having a plurality of hypermedia resources residing on one or more remote information nodes. A common remote information node is in communication with a subscriber station and the remote information nodes in the distributed network. The common remote information node contains at least one linear hypermedia resource program consisting of pre-selected media elements from one or more hypermedia resources linked with exclusive linear links, each media element in the linear program having only one forward link to the next media element. The method includes the steps of downloading and displaying a media element in the linear program and responding to user commands to download and display the next media element in the linear program. | 11-08-2012 |
Patent application number | Description | Published |
20120000825 | ADSORBENT FOR FEED AND PRODUCTS PURIFICATION IN A REFORMING PROCESS - The service life and deactivation rate of a reforming catalyst is improved through use of a new sulfur guard bed containing a chloride additive. This sulfur guard bed, which contains supported CuO material having an increased resistance to reduction, shows such improvement. Thus, the danger of run-away reduction followed by a massive release of water causing process upsets in a catalytic reforming process is practically eliminated. The fact that the guard bed material preserves the active metal phase—copper in an active (oxide) form is an important advantage leading to very low sulfur content in the product stream. The sulfur capacity per unit weight of sorbent is also significantly increased, making this sorbent a superior cost effective sulfur guard product. | 01-05-2012 |
20120004480 | ADSORBENT FOR FEED AND PRODUCTS PURIFICATION IN BENZENE SATURATION PROCESS - The service life and deactivation rate of a benzene saturation catalyst is improved through use of a new sulfur guard bed containing a chloride additive. This sulfur guard bed, which contains supported CuO material having an increased resistance to reduction, shows such improvement. Thus, the danger of run-away reduction followed by a massive release of water and deactivation of an isomerization catalyst is practically eliminated. The fact that the guard bed material preserves the active metal phase-copper in an active (oxide) form is an important advantage leading to very low sulfur content in the product stream. The sulfur capacity per unit weight of sorbent is also significantly increased, making this sorbent a superior cost effective sulfur guard product. The guard bed is effective in treating mixed phase feed streams. | 01-05-2012 |
20130074870 | TREATMENT PROCESS FOR AN ISOMERIZATION UNIT - One exemplary embodiment can be a process for treating an interior of equipment for an isomerization unit. Generally, the isomerization unit includes at least one of a drying zone, an isomerization reaction zone, and a stabilizer zone, for receiving a feed stream. Usually, the feed stream includes one or more C4-C8 hydrocarbons. The process can include combining an anhydrous hydrogen stream and anhydrous organic chloride stream to form a hydrogen chloride feedstock, and passing the hydrogen chloride feedstock to a reaction zone containing a catalyst including at least one of nickel, palladium, and platinum on an alumina support to form a hydrogen chloride stream, and passing the hydrogen chloride stream upstream of the isomerization reaction zone. | 03-28-2013 |
20130276825 | TREATMENT PROCESS FOR AN ISOMERIZATION UNIT - One exemplary embodiment can be a process for treating an interior of equipment for an isomerization unit. Generally, the isomerization unit includes at least one of a drying zone, an isomerization reaction zone, and a stabilizer zone, for receiving a feed stream. Usually, the feed stream includes one or more C4-C8 hydrocarbons. The process can include combining an anhydrous hydrogen stream and anhydrous organic chloride stream to form a hydrogen chloride feedstock, and passing the hydrogen chloride feedstock to a reaction zone containing a catalyst including at least one of nickel, palladium, and platinum on an alumina support to form a hydrogen chloride stream, and passing the hydrogen chloride stream upstream of the isomerization reaction zone. | 10-24-2013 |
20160090333 | METHODS AND APPARATUS FOR PRODUCING JET-RANGE HYDROCARBONS - Methods and apparatus are provided for producing jet-range hydrocarbons from biorenewable sources, such as oligomerizing C | 03-31-2016 |
Patent application number | Description | Published |
20100152183 | BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein. | 06-17-2010 |
20100160322 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 06-24-2010 |
20100184750 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 07-22-2010 |
20100184766 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 07-22-2010 |
20100298321 | BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein. | 11-25-2010 |
20100298323 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 11-25-2010 |
20100305122 | APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 12-02-2010 |
20110124628 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 05-26-2011 |
20110237553 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 09-29-2011 |
20120028925 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 02-02-2012 |
20120190688 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 07-26-2012 |
20120214796 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 08-23-2012 |
20130096120 | APOPTOSIS-INDUCED AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein. | 04-18-2013 |
20130096121 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bc1-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bc1-xL protein. | 04-18-2013 |
20130184278 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 07-18-2013 |
20130267514 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 10-10-2013 |
20130267534 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 10-10-2013 |
20130296295 | BCL-2 SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein. | 11-07-2013 |
20140057889 | BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein. | 02-27-2014 |
20140057890 | BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein. | 02-27-2014 |
20140066621 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 03-06-2014 |
20140088106 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 03-27-2014 |
20140094471 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 04-03-2014 |
20140107119 | BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein. | 04-17-2014 |
20140113910 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 04-24-2014 |
20150072978 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein. | 03-12-2015 |
20150152097 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein. | 06-04-2015 |
20150183775 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 07-02-2015 |
20150246914 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 09-03-2015 |
20150329541 | APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 11-19-2015 |
20160002187 | APOPTOSIS-INDUCING AGENT FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 01-07-2016 |
Patent application number | Description | Published |
20110318705 | Hydro clean auto floss - The Hydro Clean Auto Floss provides a molded mouth-guard type mouthpiece configured in a U shape to conform to the contours of a set of human teeth, having a trough to receive the teeth, further comprising an irrigation water flow component at the front thereof consisting of an attachable tubing apparatus, allowing users to floss all of the teeth by means of pressurized water, at once, whether at home or on the go. A series of small circular openings are positioned along the perimeter of the mouthpiece, serving as the egress for water. At the front of the mouthpiece is positioned the attachment point for the irrigation water flow component. The irrigation water flow component comprises one central inlet nozzle, and two outlet nozzles, positioned on each side of the inlet nozzle. All of these nozzles are designed to receive tubing by means of a force fit. At the opposite end of the inlet hose is a spout adapter that is configured to accommodate most sink faucets. | 12-29-2011 |
20120219926 | Cleaning Device for Teeth and Mouth, and Cleaning Methods - A flossing device cleans inside a mouth and essentially uses a water jet rather like a string of dental floss, to accomplish removal of particles between teeth. The device includes a mouthpiece that fits over the teeth. Advantageously no suction pump, nor power source, is included or needed in the device, which can be attached to a standard faucet. The device receives water from a standard faucet, which water exits the device from multiple holes in the mouthpiece. | 08-30-2012 |
20130165828 | CLEANING DEVICE, WITH FAUCET ADAPTER, FOR CLEANING TEETH AND MOUTH - A flossing device that includes a faucet adapter, by which the flossing device connects to an ordinary sink faucet. | 06-27-2013 |
Patent application number | Description | Published |
20100300830 | Apparatus for Removing a Contaminant from a Solvent Separation Process - The invention is a process and apparatus for removing a contaminant from an aromatic selective solvent. A feed stream comprising an aromatic hydrocarbon and a non-aromatic hydrocarbon is contacted with the aromatic selective solvent in an extractive distillation zone to produce a raffinate stream comprising the non-aromatic hydrocarbon, and a rich solvent stream comprising the aromatic hydrocarbon and the solvent. The rich solvent stream is separated in a second distillation zone to produce an extract stream comprising the aromatic hydrocarbon, and a lean solvent stream comprising the contaminant and the aromatic selective solvent. At least a portion of the lean solvent stream is washed with a non-aromatic hydrocarbon to produce a clean solvent stream, at least a portion of which is passed to at least one of the extractive distillation zone and the second distillation zone. | 12-02-2010 |
20100300939 | Process for Removing a Contaminant from an Aromatic Selective Solvent - The invention is a process and apparatus for removing a contaminant from an aromatic selective solvent. A feed stream comprising an aromatic hydrocarbon and a non-aromatic hydrocarbon is contacted with the aromatic selective solvent in an extractive distillation zone to produce a raffinate stream comprising the non-aromatic hydrocarbon, and a rich solvent stream comprising the aromatic hydrocarbon and the solvent. The rich solvent stream is separated in a second distillation zone to produce an extract stream comprising the aromatic hydrocarbon, and a lean solvent stream comprising the contaminant and the aromatic selective solvent. At least a portion of the lean solvent stream is washed with a non-aromatic hydrocarbon to produce a clean solvent stream, at least a portion of which is passed to at least one of the extractive distillation zone and the second distillation zone. | 12-02-2010 |
20120247943 | AROMATICS RECOVERY BY EXTRACTIVE DISTILLATION - The present invention relates to a process for recovering polar hydrocarbons from non-polar hydrocarbons, such as aromatics from non-aromatics, naphthenes from paraffins and isoparaffins, or olefins from paraffins and isoparaffins, in feed mixtures containing at least a measurable amount of heavier hydrocarbons. According to the invention, an improved extractive distillation (extractive-distillation) process is disclosed for recovering aromatic hydrocarbons including benzene, toluene, and xylenes from heavy (C | 10-04-2012 |
20140216915 | APPARATUS FOR REMOVING A CONTAMINANT FROM A SOLVENT SEPARATION PROCESS - The invention is a process and apparatus for removing a contaminant from an aromatic selective solvent. A feed stream comprising an aromatic hydrocarbon and a non-aromatic hydrocarbon is contacted with the aromatic selective solvent in an extractive distillation zone to produce a raffinate stream comprising the non-aromatic hydrocarbon, and a rich solvent stream comprising the aromatic hydrocarbon and the solvent. The rich solvent stream is separated in a second distillation zone to produce an extract stream comprising the aromatic hydrocarbon, and a lean solvent stream comprising the contaminant and the aromatic selective solvent. At least a portion of the lean solvent stream is washed with a non-aromatic hydrocarbon to produce a clean solvent stream, at least a portion of which is passed to at least one of the extractive distillation zone and the second distillation zone. | 08-07-2014 |
Patent application number | Description | Published |
20120032624 | Method and Apparatus for Motor Control - Various embodiments of a motor controller are disclosed. In exemplary embodiments, the motor controller can be instructed to select an operational profile based on the duration of power loss. In an exemplary embodiment, the system comprises a battery or capacitor to provide power to a microcontroller in the motor controller while power is disconnected. | 02-09-2012 |
20120032629 | Electric Motor and Motor Control - Various embodiments of an electric motor and electronic control for an electric motor are disclosed. An exemplary electric motor comprises a single-phase brushless permanent magnet electric motor. In exemplary embodiments, the electronic motor control is configured to commutate an electric motor at a frequency other than line frequency, perform pulse width modulation, and drive the electric motor with a drive waveform that approximates the counter-electromotive force of the motor. | 02-09-2012 |
20140055063 | ELECTRIC MOTOR AND MOTOR CONTROL - Various embodiments of an electric motor and electronic control for an electric motor are disclosed. An exemplary electric motor comprises a single-phase brushless permanent magnet electric motor. In exemplary embodiments, the electronic motor control is configured to commutate an electric motor at a frequency other than line frequency, perform pulse width modulation, and drive the electric motor with a drive waveform that approximates the counter-electromotive force of the motor. | 02-27-2014 |
20150226805 | SYSTEMS, DEVICES, AND METHODS FOR MOTOR MONITORING - A data acquisition device that can be coupled with any motor, even those already in service, to automatically monitor the operation of the motor and provide alerts when the motor is in need of repair or replacement. The data acquisition device senses conditions of the motor and transmits sensor data to a computer system or other remote monitoring device so that the remote monitoring device can determine if the motor needs to be repaired or replaced. The data acquisition device also acquires location data and sends it to the remote monitoring device so that a technician or other person can quickly locate the motor. | 08-13-2015 |